Atlas Trials

Study of Safety and Tolerability of PCI-27483 in Patients With Pancreatic Cancer Patients Receiving Treatment With Gemcitabine

Clinical trial NCT01020006 · COMPLETED

Trial details

NCT number
NCT01020006
Sponsor
Pharmacyclics LLC.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Pancreatic CancerDuctal AdrenocarcinomaExocrine Pancreatic Cancer
Start date
2009-11-01
Primary completion
2012-08-01
Enrollment
42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.